Medtronic Minimed
Medtronic MiniMed is a world
leader in insulin pump therapy and continuous glucose monitoring for the
treatment of diabetes. The company is committed to improving the lives
of people living with diabetes and other medical conditions by providing
integrated therapy solutions, including superior drug delivery and glucose
monitoring devices, data management tools, pharmaceuticals and responsive
customer service.
MiniMed was founded in the early 1980s, the company's
core business is insulin pump therapy for the treatment of Type 1 diabetes.
In July 2002, MiniMed integrated with Medtronic Limited and became known
worldwide as Medtronic MiniMed. More than 150,000 Medtronic MiniMed pump
wearers worldwide, including customers who purchased the company's first
insulin pump in 1983, are supported by a clinical services team 24 hours
a day, 365 days a year. The company also assists customers training for
pump initiation, and provides ongoing educational support for physicians
and diabetes patients. Educational programs are directed to the healthcare
community through continuing educational programs, nationwide symposia
and a pump trainer program.
Medtronic MiniMed employs more than 2,000 people
worldwide. Customer support (sales processing, insurance verification,
clinical services, billing and collections), marketing, research and development,
and the manufacturing of insulin pumps and continuous glucose monitoring
systems are located at its corporate headquarters in California, USA.
The international headquarters are located in Tolochenaz, Switzerland.
For
more information on Medtronic MiniMed
